IMMUNOPHENOTYPE ABERRANCE OF MARROW CELLS IN PRIMARY MYELODYSPLASTIC SYNDROMES
https://doi.org/10.51523/2708-6011.2011-8-2s-11
Abstract
About the Authors
N. N. KlimkovichBelarus
T. I. Kozarezova
Belarus
V. V. Smolnikova
Belarus
L. V. Kolbasko
Belarus
D. I. Suvorov
Belarus
I. A. Iskrov
Belarus
References
1. Прогностическое значение иммунофенотипа злокачественных клеток (на примере острых нелимфобластных лейкозов) / И. Г. Маркина [и др.] // Рус. мед. журнал. - 2001. - Т. 9, № 22. - С. 1003-1008.
2. Myelodysplastic syndromes/neoplasms, overview / R. D. Brunning [et al.] // In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues / Ed. by S. H. Swerdlow [et al.] // Lyon: IARC. - 2008. - Vol. 2. - P. 88-93.
3. Stetler-Stevenson, M. Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis / M. Stetler-Stevenson, C. M. Yuan // International Journal of Laboratory Hematology. - 2009. - Vol. 31, № 5. - Р. 479-483.
Review
For citations:
Klimkovich N.N., Kozarezova T.I., Smolnikova V.V., Kolbasko L.V., Suvorov D.I., Iskrov I.A. IMMUNOPHENOTYPE ABERRANCE OF MARROW CELLS IN PRIMARY MYELODYSPLASTIC SYNDROMES. Health and Ecology Issues. 2011;(2S):37-40. (In Russ.) https://doi.org/10.51523/2708-6011.2011-8-2s-11